Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GMB: Truvada vs Emtricitabine in HIV HAART Interruption
NCT00362687Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Nov 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil, emtricitabine in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences. Started Nov 2006; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxilemtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00362687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362687.